Search hospitals
>
California
>
Torrance
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Claim this profile
Torrance, California 90502
Global Leader in Cancer
Conducts research for Brain Tumor
Conducts research for Solid Tumors
Conducts research for Brain Cancer
Conducts research for Non-Hodgkin's Lymphoma
103 reported clinical trials
8 medical researchers
Summary
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center is a medical facility located in Torrance, California. This center is recognized for care of Cancer, Brain Tumor, Solid Tumors, Brain Cancer, Non-Hodgkin's Lymphoma and other specialties. Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center is involved with conducting 103 clinical trials across 318 conditions. There are 8 research doctors associated with this hospital, such as Eduard H. Panosyan, George A Karpouzas, MD, William French, MD, and Loren G Miller.
Area of expertise
Cancer
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center has run 15 trials for Cancer. Some of their research focus areas include:
Brain Tumor
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center has run 9 trials for Brain Tumor. Some of their research focus areas include:
Top PIs
Eduard H. Panosyan
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
8 years of reported clinical research
George A Karpouzas, MD
The Lundquist Institute at Harbor-UCLA Medical Center
3 years of reported clinical research
William French, MD
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
4 years of reported clinical research
Loren G Miller
GSK Investigational Site
7 years of reported clinical research
Clinical Trials running at Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Cancer
Testicular cancer
Type 2 Diabetes
Cardiovascular Disease
Ovarian Carcinoma
Ovarian Tumors
Testicular Carcinoma
Ovarian Choriocarcinoma
Myelofibrosis
Stroke
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting
2 awards
Phase 3
26 criteria
LY3537982 + Immunotherapy/Chemotherapy
for Non-Small Cell Lung Cancer
This trial is testing a new drug, LY3537982, combined with standard treatments for patients with advanced lung cancer that have a specific genetic mutation. The goal is to see if this combination works better than the usual treatments alone.
Recruiting
1 award
Phase 3
14 criteria
Health Information Collection
for Childhood Cancer
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Recruiting
1 award
N/A
10 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center?
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center is a medical facility located in Torrance, California. This center is recognized for care of Cancer, Brain Tumor, Solid Tumors, Brain Cancer, Non-Hodgkin's Lymphoma and other specialties. Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center is involved with conducting 103 clinical trials across 318 conditions. There are 8 research doctors associated with this hospital, such as Eduard H. Panosyan, George A Karpouzas, MD, William French, MD, and Loren G Miller.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.